Background and Physiology of Coagulation

Similar documents
MCHENRY WESTERN LAKE COUNTY EMS SYSTEM OPTIONAL CE ADVANCED LEVEL (EMTP, PHRN, ECRN) August Anticoagulants

VPM 152. INFLAMMATION: Chemical Mediators

New Oral Anticoagulants

Note: Page numbers in italics indicate figures. Page numbers followed by a t indicate tables.

Platelet Review July Thomas S. Kickler M.D. Johns Hopkins University School of Medicine

LABORATORY DIAGNOSIS OF BLEEDING DISORDERS

Lupus anticoagulant Pocket card

Disclosure. New Agents for Treatment of DVT. Prevalence of DVT VTE. Normal Hemostasis 7/17/2015. Mark Oliver, MD, RVT, RPVI,FSVU

Coagulation Made Simple. Thomas A. Whitehill, M.D. Section of Vascular Surgery

Laboratory Testing in Patients on Novel Oral Anticoagulants (NOACs)

Hemostasis. Bleeding and Clotting. Hemostasis. Platelet Function. Platelet Degranulation Products

Regulation of enzyme activity

Breaking Old Habits: Use of the New Oral Anticoagulants in Clinical Practice

Bleeding disorders or haemorrhagic diatheses are a group of disorders characterised by defective haemostasis with abnormal bleeding.

Thibodeau: Anatomy and Physiology, 5/e. Chapter 17: Blood

Simulation of Thrombin Generation During Plasmatic Coagulation and Primary Hemostasis

Hemostasis analyzer system

Reversal of Antiplatelet and Anticoagulant Therapy: What You Need To Know. Ronald Walsh, MD Chief Medical Officer Community Blood Services

Please list four delivery functions of blood, two regulatory functions, and two protection functions. Delivery (distribution) functions

Overview of Inflammation and Coagulation Brenda Lynn Morgan RN BScN MSc CNCC(C)

Blood Management Today Incorporating TEG

Platelet Function analysis using Multiple Electrode Aggregometry (Multiplate )

Blood. Blood. Blood Composition. Blood Composition. Fractionation & Hemopoesis

Actions of Hormones on Target Cells Page 1. Actions of Hormones on Target Cells Page 2. Goals/ What You Need to Know Goals What You Need to Know

Monitoring Thrombin Generation: The Holy Grail of Laboratory Hemostatic Assessment.

Per Morten Sandset Hemostasis parameters and medication prior to radiological interventions

Antithromboticthrombotic Monitoring

What You Should Know About Abnormal Blood Clotting

BLOOD Dr. Ali Ebneshahidi

DISCLOSURES CONFLICT CATEGORY. No conflict of interest to disclose

Functions of Blood. Collects O 2 from lungs, nutrients from digestive tract, and waste products from tissues Helps maintain homeostasis

PLATELETS: OVERVIEW. J. Kelton, M.D. May 3 rd, 2003

Chapter-21b: Hormones and Receptors

Role of Fitted Reaction Rates in Predicting Thrombin Production


Pharmacology of Antiplatelet and Anticoagulants Agents

ENZYMES (DR. NUGENT)

Sign up to receive ATOTW weekly

3. The Circulatory System

B.PHARM. I st SEMESTER SUBJECT: HAP SUBJECT CODE: AS 2503

KEY CHAPTER 14: BLOOD OBJECTIVES. 1. Describe blood according to its tissue type and major functions.

Hot Topics: Current PFO Recommendations and Loop Monitoring/Cryptogenic Stroke.

Energy & Enzymes. Life requires energy for maintenance of order, growth, and reproduction. The energy living things use is chemical energy.

Xarelto and the New Orals

Contents. Abstract... i. Committee Membership... iii. Foreword... vii. 1 Scope Introduction Standard Precautions...

HANDBOOK OF DIAGNOSTIC HEMOSTASIS AND THROMBOSIS TESTS

Analytical Specifications RIVAROXABAN

CHAPTER 6 AN INTRODUCTION TO METABOLISM. Section B: Enzymes

To aid practitioners in prescribing unfractionated heparin and low-molecular-weight heparins to patients.

Anticoagulation and Reversal

A Cell-based Model of Hemostasis

Yvette Marie Miller, M.D. Executive Medical Officer American Red Cross October 20, th Annual Great Lakes Cancer Nursing Conference Troy, MI

Cyclooxygenase and NSAIDs

Abnormal Basic Coagulation Testing Laboratory Testing Algorithms

Blood Questions. 8. A reduced ability to produce thrombin would cause the time required for blood clot formation to:

New Anticoagulants: When and Why Should I Use Them? Disclosures

Continuing Education Course #2: Current Understanding of Hemostasis

Chemical Basis of Life Module A Anchor 2

Perioperative management of Dual Antiplatelet therapy post drug eluting stent-changing time

Multiplate platelet function analysis - application and interpretation

From the Department of Biochemistry, University of Vermont, Burlington, Vermont

Chemistry 20 Chapters 15 Enzymes

Keystone Review Practice Test Module A Cells and Cell Processes. 1. Which characteristic is shared by all prokaryotes and eukaryotes?

8/20/2012 H C OH H R. Proteins

Lecture. DRUGS ACTING ON BLOOD COAGULATION AND FIBRINOLYSIS (dental faculty)

Smooth Muscle. Smooth Muscle Structure

Copyright Mark Brandt, Ph.D. 54

Coagulation Inhibitor Potential:

Hemostas under graviditet och förlossning. Ove Karlsson Sahlgrenska Universitetssjukhuset

Thrombophilia. Steven R. Lentz, M.D. Ph.D. Carver College of Medicine The University of Iowa May 2003

How to Interpret and Pursue an Abnormal Prothrombin Time, Activated Partial Thromboplastin Time, and Bleeding Time in Adults

21.8 The Citric Acid Cycle

Blood & Hematology. The human body is made up mostly of water; ~60-65% (40 L)


Arterial and venous thrombosis are major causes of. New Anticoagulant Drugs. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

Medical Snippets. The best bits from our top titles! The history of our historic and globally recognised emblem

New Treatment Options in the Management of Sepsis

Anatomy and Physiology Placement Exam 2 Practice with Answers at End!

New Anticoagulation Options for Stroke Prevention in Atrial Fibrillation. Joy Wahawisan, Pharm.D., BCPS April 25, 2012

Lupus anticoagulant aptt & drvvt screening panel W Reflex

The Structure and Function of Macromolecules: Carbohydrates, Lipids & Phospholipids

Management of Patients on Anticoagulants. Haemostasis. Coagulation cascade. Cell-based model 19/11/2013

Session 3 Topics. Argatroban. Argatroban. Drug Use and Adverse Effects. Laboratory Monitoring of Anticoagulant Therapy

Copyright The McGraw-Hill Companies, Inc. Permission required for reproduction or display. Two Forms of Energy

BSC Exam I Lectures and Text Pages. The Plasma Membrane Structure and Function. Phospholipids. I. Intro to Biology (2-29) II.

What affects an enzyme s activity? General environmental factors, such as temperature and ph. Chemicals that specifically influence the enzyme.

LIVER FUNCTION TESTS

Biology. Slide 1of 51. End Show. Copyright Pearson Prentice Hall

Inflammation. A normal response of living tissues to injury. It prepares the tissue for healing and repair.

1. A covalent bond between two atoms represents what kind of energy? a. Kinetic energy b. Potential energy c. Mechanical energy d.

UNIT 3 : MAINTAINING DYNAMIC EQUILIBRIUM

Human Anatomy & Physiology II with Dr. Hubley

Chapter 3 Molecules of Cells

Carbohydrates, proteins and lipids

Venous Thrombo-Embolism (VTE) Therapy current challenges & opportunities

Thrombin Generation Assay

Cardiology Medications New Drugs, New Guidelines

Microscopy of blood clot dissolution

DVT/PE Management with Rivaroxaban (Xarelto)

New anticoagulants: Monitoring or not Monitoring? Not Monitoring

Transcription:

Objectives Background and Physiology of Coagulation Sarah M. Westberg, Pharm.D., BCPS Understand the physiology of how a thrombosis is formed and dissolved within the body Describe the role of platelets in forming a thrombosis Describe the role of the coagulation cascade in forming a thrombosis Be able to describe the natural processes by which clots are dissolved Hemostatic Balance Platelet Functions Adhesion Secretion Aggregation Fusion Platelet Structure Platelet Adhesion When subendothelial connective tissues are exposed in the blood, platelet adhere to that exposed tissue Subendothelial microfibrils bind to VWF, which then binds to GPIb binding site on the platelet

Platelet Adhesion Platelet Activation After adhesion, platelets will change shape, extrude long pseudopods which enhance platelet interaction Activated platelets adhere to exposed collagen by GPIb and vwf. Platelet Aggregation Platelet Secretion Aggregation begins immediately, prompted by presence of fibrinogen binding to GPIIb/IIIa complex Fibrinogen bridges form between adjacent platelets Once exposed to collagen or thrombin, platelets will secrete some of their granule contents (AFP, serotonin, fibrinogen, calcium) Activate prostaglandin synthesis, leading to production of thromboxane A2 (TXA2). Thromboxane A2 potentiates platelet aggregation and causes vasoconstriction Platelet/ Endothelial Cell ENDOTHELIAL CELL Phospholipid Phospholipase Arachidonic acid Cyclooxygenase 2 Endoperoxides Prostacyclin synthase Prostacyclin PLATELET Phospholipid Phospholipase Arachidonic acid Cyclooxygenase 1 Endoperoxides Thromboxane synthase Thromboxane A2 ATP - Adenylate cyclase + camp Phosphodiasterase AMP Lowers Calcium Platelet Aggregation Once ADP and thromboxane A2 are released (during secretion), more platelets aggregate ADP causes platelets to swell, adjacent platelet adhere to each other Liberates more ADP and thromboxane A2, therefore causing positive feedback Eventually build a platelet mass

Platelet Fusion Platelet Procoagulant Activity Irreversible platelet aggregation Thrombin encourages fusion Fibrin reinforces stability High concentrations of ADP, other enzymes released during secretion and platelet contractile proteins contribute to fusion The exposed phospholipid membrane on the activated platelet leads to : Formation of factor Xa (through IXa, VIIIa, and X) Formation of thrombin [from Xa, Va and prothrombin (II)] Role of coagulation cascade A biological amplification system which ends in the generation of thrombin Thrombin converts fibrinogen into fibrin. Fibrin enmeshes the platelets and converts unstable platelet plugs to firm stable hemostatic plugs Common Pathway Intrinsic Pathway Endothelial injury XII XI Ca ++ IX X VIII + Ca ++ XIIa XIa IXa II (prothrombin) Inhibitors Fibrinogen Warfarin Unfractionated Heparin Protein C Va + Ca ++ Ca ++ Fibrin Xa Stable Fibrin Clot Extrinsic Pathway Tissue Damage VII VIIa IIa(thrombin) XIIIa Ca ++ /tissue factor Antithrombin III (ATIII) Ca ++ XIII Coagulation Cascade Intrinsic Pathway Extrinsic/Tissue Factor Pathway Coagulation Cascade

Lipid Membrane Fibrin When fibrinogen is hydrolyzed by thrombin, fibrin monomers are formed These link to form a loose, insoluble fibrin polymer Factor XIII is activated by thrombin and calcium, and helps stabilize the fibrin polymers with covalent bond cross links Platelet-Fibrin Clot Natural limitations of coagulation Tissue factor pathway inhibitor (tfpi) accumulates at site of injury Inhibits Xa and VIIa and tissue factor Antithrombin inactivates serine proteases by forming high molecular weight stable complexes Protein C and Protein S Protein C is activated when thrombin binds to endothelial cell surface receptor thrombomodulin. Protein C destroys factors Va and VIIIa Protein S is a co-factor which facilitates binding of activated protein C to the platelet surface. Natural limitations of coagulation Fibrinolysis Fibrinolysis Plasminogen is converted to plasmin primarily by tissue plasminogen activator (tpa) tpa is released from the endothelial cells tpa binds to fibrin, and converts plasminogen in the thrombus to plasmin Protein C protects tpa by destroying inhibitors of tpa Plasmin digests fibrinogen, fibrin, factors V and VIII and others

Role of Endothelial Cells Hemostatic Process #1 Work to synthesize PGI2 and nitric oxide, which cause vasodilation and inhibit platelet aggregation Release tpa and activate fibrinolysis Synthesizes: Tissue factor & it s inhibitor (TFPI) Prostacyclin VWF Plasminogen activator Antithrombin and thrombomodulin Hemostatic Process #2 Hemostatic Process #3 Hemostatic Process #4 Hemostatic Process #5

Vessel Injury Collagen Exposure Vasoconstriction Platelet Adhesion and Release Reaction Thromboxane A2, ADP Platelet phospholipid Tissue Factor Reduced blood flow Platelet Aggregation Primary Hemostatic Plug Platelet fusion Stable haemostatic plug Blood coagulation cascade Thrombin Fibrin